SAN FRANCISCO, CA, Verana Health, a digital health company, announced a $150 million Series E funding round led by Johnson & Johnson Innovation and Novo Growth.
Verana Health, a digital health company, announced a $150 million Series E funding round led by Johnson & Johnson Innovation - JJDC, Inc. (JJDC) and Novo Growth, the growth-stage investment arm of Novo Holdings.
Existing Verana Health investors GV (formerly Google Ventures), Casdin Capital, and Brook Byers also joined the round, as well as notable new investors, including the Merck Global Health Innovation Fund, THVC, and Breyer Capital.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
